New study observes patients getting nasal stem cell therapy for brain conditions
NCT ID NCT07521384
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study follows 36 people with neurologic conditions like traumatic brain injury, cerebral palsy, multiple sclerosis, or Alzheimer's who are already receiving intranasal MuSE stem cell or exosome therapy as part of their routine care. Researchers track safety and changes in a key inflammation marker (TNF-α) over time. The goal is to gather real-world data on how these regenerative treatments affect the body, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MuSE cell derived exosomes, MuSE stem cells, or combination therapy delivered intranasally via the ViaNase device
What this could lead to
If successful, this study could provide early evidence on whether these regenerative therapies are safe and reduce inflammation in the brain, pointing toward future treatments for conditions like traumatic brain injury, multiple sclerosis, and Alzheimer's.
What could go wrong
This is a small, early observational study (36 participants) that does not assign treatment or compare against a placebo. Results may not prove effectiveness or apply to broader populations. Risks include unknown side effects from the intranasal delivery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXIC ISCHEMIC ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stem Solutions
Monterrey, Nuevo León, Mexico